As of 22 Oct 2026, Caplin Point Laboratories Ltd share price is ₹2,250.40. The stock opened at ₹2,250.40 and had closed at ₹2,221.20 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹1,502.45 and a high of ₹2,990.60. In terms of performance, Caplin Point Laboratories Ltd share price has increased by 29.38% over the past six months and has increased by 9.62% over the last year.
CAPLIPOINT Stock Price Chart
Caplin Point Laboratories Ltd Overview
About CAPLIPOINT
Caplin Point Laboratories is a progressive pharmaceutical company engaged in the manufacturing and marketing of finished formulations, manufacturing of Active Pharmaceutical Ingredients, Research & Development and Clinical Research. Its unique business model mostly caters to emerging markets of Latin America and Africa. Over the years, with focused and consistent approach, Caplin has established a growing presence in the regulated markets such as the USA.
Caplin Point Laboratories Ltd Historical Performance
Caplin Point Laboratories Ltd Fundamentals
Caplin Point Laboratories Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 933.70 | 887.00 | 730.93 | 627.61 | 584.61 |
| EBITDA | 533.15 | 466.56 | 392.92 | 318.92 | 276.17 |
| Net Profit | 396.58 | 339.49 | 283.71 | 234.26 | 187.87 |
| EPS | 52.17 | 44.67 | 37.36 | 30.89 | 24.82 |
Caplin Point Laboratories Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 2,196.37 |
| Resistance 1 (R1) | 2,258.92 |
| Pivot Point | 2,234.08 |
Caplin Point Laboratories Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 18-Sep-2026 | 12-Aug-2026 | 18-Sep-2026 | Final | ₹4.00 |
| 29-May-2026 | 14-May-2026 | 30-May-2026 | Interim | ₹4.00 |
| 12-Sep-2025 | 07-Aug-2025 | 12-Sep-2025 | Final | ₹3.00 |
| 30-May-2025 | 15-May-2025 | 30-May-2025 | Interim | ₹3.00 |
| 23-Sep-2024 | 07-Aug-2024 | 23-Sep-2024 | Final | ₹2.50 |
CAPLIPOINT Key Leadership Details
Last Updated: Mar 2025
| Name | Position |
|---|---|
| C C Paarthipan | Chairman |
| Sridhar Ganesan | Managing Director |
| R Vijayaraghavan | Non Executive Independent Director |
Caplin Point Laboratories Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,758.00+0.74% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,162.00-0.30% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,615.30+1.35% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Caplin Point Laboratories Ltd today is ₹2,250.40 on NSE and ₹2,250.40 on BSE.
- The 52-week high of Caplin Point Laboratories Ltd is ₹2,990.60, while the 52-week low is ₹1,502.45.
- The current market capitalisation of Caplin Point Laboratories Ltd is approximately ₹16,884 crore.
- The P/E (Price-to-Earnings) ratio of Caplin Point Laboratories Ltd is 20.16. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Caplin Point Laboratories Ltd is 3.97. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Caplin Point Laboratories Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for CAPLIPOINT on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Caplin Point Laboratories Ltd has delivered a return of approximately 108.85%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Caplin Point Laboratories Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 70.57% promoters, 3.73% FIIs, 2.49% DIIs, and 14.62% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
